These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 23766705)

  • 1. Alternative splicing for diseases, cancers, drugs, and databases.
    Tang JY; Lee JC; Hou MF; Wang CL; Chen CC; Huang HW; Chang HW
    ScientificWorldJournal; 2013; 2013():703568. PubMed ID: 23766705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA mis-splicing in disease.
    Scotti MM; Swanson MS
    Nat Rev Genet; 2016 Jan; 17(1):19-32. PubMed ID: 26593421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OncoSplicing: an updated database for clinically relevant alternative splicing in 33 human cancers.
    Zhang Y; Yao X; Zhou H; Wu X; Tian J; Zeng J; Yan L; Duan C; Liu H; Li H; Chen K; Hu Z; Ye Z; Xu H
    Nucleic Acids Res; 2022 Jan; 50(D1):D1340-D1347. PubMed ID: 34554251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases.
    Mercatante DR; Sazani P; Kole R
    Curr Cancer Drug Targets; 2001 Nov; 1(3):211-30. PubMed ID: 12188880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative Splicing as a Target for Cancer Treatment.
    Martinez-Montiel N; Rosas-Murrieta NH; Anaya Ruiz M; Monjaraz-Guzman E; Martinez-Contreras R
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of splicing in cancer.
    Lee SC; Abdel-Wahab O
    Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment.
    Lin JC
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perspectives of RNA interference application in the therapy of diseases associated with defects in alternative RNA splicing].
    Wysokiński D; Błasiak J
    Postepy Hig Med Dosw (Online); 2012 Sep; 66():683-95. PubMed ID: 23001210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of alternative splicing in cancer: From oncogenesis to drug resistance.
    Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J
    Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy.
    Mehterov N; Kazakova M; Sbirkov Y; Vladimirov B; Belev N; Yaneva G; Todorova K; Hayrabedyan S; Sarafian V
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of alternative splicing pathways as a potential approach to chemotherapy.
    Mercatante D; Kole R
    Pharmacol Ther; 2000 Mar; 85(3):237-43. PubMed ID: 10739878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASCancer Atlas: a comprehensive knowledgebase of alternative splicing in human cancers.
    Wu S; Huang Y; Zhang M; Gong Z; Wang G; Zheng X; Zong W; Zhao W; Xing P; Li R; Liu Z; Bao Y
    Nucleic Acids Res; 2023 Jan; 51(D1):D1196-D1204. PubMed ID: 36318242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative splicing: an emerging topic in molecular and clinical oncology.
    Pajares MJ; Ezponda T; Catena R; Calvo A; Pio R; Montuenga LM
    Lancet Oncol; 2007 Apr; 8(4):349-57. PubMed ID: 17395108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing in cancers: From aberrant regulation to new therapeutics.
    Song X; Zeng Z; Wei H; Wang Z
    Semin Cell Dev Biol; 2018 Mar; 75():13-22. PubMed ID: 28919308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SnapShot: Splicing Alterations in Cancer.
    Rahman MA; Krainer AR; Abdel-Wahab O
    Cell; 2020 Jan; 180(1):208-208.e1. PubMed ID: 31951519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha regulates alternative splicing of genes participating in pathways of crucial metabolic syndromes; a transcriptome wide study.
    Louis JM; Vaz C; Balaji A; Tanavde V; Talukdar I
    Cytokine; 2020 Jan; 125():154815. PubMed ID: 31476685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splicing Regulators and Their Roles in Cancer Biology and Therapy.
    da Silva MR; Moreira GA; Gonçalves da Silva RA; de Almeida Alves Barbosa É; Pais Siqueira R; Teixera RR; Almeida MR; Silva Júnior A; Fietto JL; Bressan GC
    Biomed Res Int; 2015; 2015():150514. PubMed ID: 26273588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome-wide identification and study of cancer-specific splicing events across multiple tumors.
    Tsai YS; Dominguez D; Gomez SM; Wang Z
    Oncotarget; 2015 Mar; 6(9):6825-39. PubMed ID: 25749525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative Splicing: Recent Insights into Mechanisms and Functional Roles.
    Ghigna C; Paronetto MP
    Cells; 2020 Oct; 9(10):. PubMed ID: 33092102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicing.
    Dvinge H; Guenthoer J; Porter PL; Bradley RK
    Genome Res; 2019 Oct; 29(10):1591-1604. PubMed ID: 31434678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.